Overview

ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors

Status:
Unknown status

Trial end date:
2017-07-01

Target enrollment:

Participant gender:

Summary

The clinical application and effect of ATG based myeloablative conditioning regimen after allogeneic hematopoietic stem cell transplantation in adult patients with aggressive T-cell lymphomas.

Details

Lead Sponsor:

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators:

Tang-Du Hospital
The First Affiliated Hospital of Soochow University
The First Affiliated Hospital with Nanjing Medical University

Treatments:

Thymoglobulin